BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

HEALIANCE PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Termination

HEALIANCE PHARMACEUTICALS

via DELAHUNT GROUP, LLC

3rd Quarter (July 1 - Sep 30) · 2014Posted Sept 23, 2014Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: HEALIANCE PHARMACEUTICALS
Description: medical innovation
Location: New Jersey · United States of America

Registrant

Firm: DELAHUNT GROUP, LLC
Description: Consulting, government affairs
Location: Quincy, Massachusetts, United States of America

Lobbying activities

1 issue

Foreign Relations
Issues related to issuance of supplemental OFAC license
LobbyistsWILLIAM DELAHUNT

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.